Furthermore, the expression of HDACs (HDAC1 and HDAC2) that interact with the PRC2 complex was also negatively correlated with PTEN expression (Fig. 1d, Supplementary Data 2), consistent with the result of TSA treatment in breast cancer cell lines. This evidence concerns the gene HDAC2 and breast carcinoma.